Should you add Jazz Pharmaceuticals PLC (JAZZ) stock to your portfolio on Wednesday?

Hill 63 InvestorsObserver gives shares of Jazz Pharmaceuticals PLC (JAZZ) puts it near the top of the healthcare sector. In addition to scoring more than 95% of healthcare stocks, JAZZ’s overall rating of 63 means the stock scores better than 63 of all stocks.

JAZZ has an overall score of 63. Find out what this means for you and get the rest of the rankings on JAZZ!

What do these notes mean?

Finding the best stocks can be tricky. It is not easy to compare companies from one sector to another. Even companies in the healthcare industry can sometimes be difficult to compare. InvestorsObserverThe tools allow for a top-down approach that lets you pick a metric, find the best sector and industry, and then find the best stocks in that sector. These rankings allow you to easily compare stocks and see what the strengths and weaknesses of a given company are. This lets you find the stocks with the best short and long-term growth prospects in seconds. The combined score incorporates technical and fundamental analysis to provide a comprehensive view of a stock’s performance. Investors who then want to focus on analyst rankings or valuations can view separate scores for each section.

What’s going on with Jazz Pharmaceuticals PLC shares today?

Jazz Pharmaceuticals PLC (JAZZ) stock is trading at $157.86 at 2:57 p.m. on Wednesday, March 30, a loss of -$0.29, or -0.18% from the previous closing price of 158 .15$. Today, the volume is below average. So far, 153,028 shares have been traded against an average volume of 610,269 shares. The stock has traded between $157.51 and $159.90 so far today. Click here for the full Jazz Pharmaceuticals PLC stock report.

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.

Thank you for signing up! You are ready to receive the Morning Update newsletter

Ada J. Kenney